La última palabra en dosis mínima

Página do item simplificado
dc.contributor.authorFernandes, César Eduardo [UNESP]
dc.contributor.authorDe Azevedo, Lucía Helena
dc.contributor.authorStephan, Cristina
dc.contributor.authorDe Souza Ferreira, José Arnaldo
dc.contributor.authorDe Melo, Nilson Roberto
dc.contributor.authorPeixoto, Sergio
dc.contributor.institutionFacultad de Medicina de ABC
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-27T11:21:23Z
dc.date.available2014-05-27T11:21:23Z
dc.date.issued2005-07-01
dc.description.abstractIn this article we rewiewed the indications of the low-dose hormone replacement therapy in post menopausal women. We evaluate the effects of this therapy on menopausal symptoms bone metabolism, cardiovascular risk and endometrial cancer. The low-dose hormone replacement therapy is satisfactory to relief menopausal symptoms and improves lipid profile preventing atherosclerosis. It does not increase the risk of hyperplasia or endometrial cancer when is associate with progestagens. The low dose hormone replacement therapy is also associate to improve bone mineral density but to have better comprehension about the effective action of the low dose hormone replacement therapy on bone, more studies evaluating the risk of fractures are necessary.en
dc.description.affiliationDisciplina de Ginecología y Obstetricia Facultad de Medicina de ABC, São Paulo
dc.description.affiliationDepartamento de Ginecología y Obstetricia Facultad de Medicina de Botucatu UNESP
dc.description.affiliationDepartamento de Ginecología y Obstetricia Facultad de Medicina de USP, São Paulo
dc.description.affiliation, Rua Pedro Vitor Massote, 18, São Paulo 05396-420
dc.description.affiliationUnespDepartamento de Ginecología y Obstetricia Facultad de Medicina de Botucatu UNESP
dc.format.extent13-19
dc.identifier.citationRevista Iberoamericana de Revisiones en Menopausia, v. 7, n. 3, p. 13-19, 2005.
dc.identifier.issn1139-4773
dc.identifier.scopus2-s2.0-25444488516
dc.identifier.urihttp://hdl.handle.net/11449/68336
dc.language.isospa
dc.relation.ispartofRevista Iberoamericana de Revisiones en Menopausia
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectBone metabolism
dc.subjectCardiovascular risk
dc.subjectEndometrial cancer
dc.subjectLow dose
dc.subjectMenopausal symptoms
dc.subjectgestagen
dc.subjectatherosclerosis
dc.subjectbone metabolism
dc.subjectcardiovascular risk
dc.subjectendometrium cancer
dc.subjecthormonal therapy
dc.subjecthuman
dc.subjecthyperplasia
dc.subjectlow drug dose
dc.subjectmenopausal syndrome
dc.subjectpostmenopause
dc.subjectreview
dc.titleLa última palabra en dosis mínimaes
dc.title.alternativeFinal word on minimum doseen
dc.typeResenha
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt

Arquivos

Coleções

Artigos - Ginecologia e Obstetrícia - FMB